Carole Ho

2018

In 2018, Carole Ho earned a total compensation of $3.9M as Chief Medical Officer at Denali Therapeutics, a 188% increase compared to previous year.

Compensation breakdown

Bonus$371,187
Option Awards$2,948,616
Salary$423,124
Stock Awards$179,673
Other$12,869
Total$3,935,469

Ho received $2.9M in option awards, accounting for 75% of the total pay in 2018.

Ho also received $371.2K in bonus, $423.1K in salary, $179.7K in stock awards and $12.9K in other compensation.

Rankings

In 2018, Carole Ho's compensation ranked 2,842nd out of 14,244 executives tracked by ExecPay. In other words, Ho earned more than 80.0% of executives.

ClassificationRankingPercentile
All
2,842
out of 14,244
80th
Division
Manufacturing
1,050
out of 5,765
82nd
Major group
Chemicals And Allied Products
362
out of 2,128
83rd
Industry group
Drugs
296
out of 1,817
84th
Industry
Biological Products, Except Diagnostic Substances
65
out of 339
81st
Source: SEC filing on April 18, 2019.

Ho's colleagues

We found three more compensation records of executives who worked with Carole Ho at Denali Therapeutics in 2018.

2018

Ryan Watts

Denali Therapeutics

Chief Executive Officer

2018

Steve Krognes

Denali Therapeutics

Chief Financial Officer

2018

Alexander Schuth

Denali Therapeutics

Chief Operating Officer

News

In-depth

You may also like